• Pro Medicus invests $10m into 4DMedical
• Investment to accelerate 4DMedical's commercial pipeline and advance CT:VQ™ towards US regulatory clearance
• Investment structured as a hybrid debt and equity loan

4DMedical Limited, a global leader in respiratory imaging technology, has announced that it has entered into a secured facility agreement with Pro Medicus Limited, a global leader in medical imaging software and solutions, to provide 4DMedical with $10m. This strategic investment will provide 4DMedical with the growth capital to accelerate its commercial pipeline for existing products while advancing CT:VQ™ towards regulatory clearance in the United States. The Facility Agreement includes security as collateral, and the material terms are set out in Annexure 1. Pro Medicus is an ASX-listed global healthcare technology company with over 30 years of experience in medical imaging software and integrated informatics solutions. The company has established itself as a trusted partner to major healthcare institutions worldwide, including Mayo Clinic, Johns Hopkins, and other leading hospitals and imaging centres across the U.S., Europe and Australia. 4DMedical's MD/CEO and Founder, Andreas Fouras, stated that this strategic investment from Pro Medicus places the company in a strong position to take CT:VQ™ to market once it is cleared by the FDA. He highlighted the rapid growth in sites and scans, the growing momentum in the Philips partnership, and the shortening timeline to expected FDA clearance of CT:VQ™, setting the company up for extremely strong performance in the coming months.